Avenue Therapeutics Inc’s filing revealed that its Director KRANZLER JAY D acquired Company’s shares for reported $1242.0 on Sep 30 ’24. In the deal valued at $2.50 per share,497 shares were bought. As a result of this transaction, KRANZLER JAY D now holds 620 shares worth roughly $1240.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, KRANZLER JAY D bought 3 shares, generating $7 in total proceeds. Upon buying the shares at $2.40, the Director now owns 123 shares.
Before that, Davidow Robert L sold 353,000 shares. Avenue Therapeutics Inc shares valued at $49,600 were divested by the 10% Owner at a price of $0.14 per share. As a result of the transaction, Davidow Robert L now holds 22,000 shares, worth roughly $44000.0.
Price Performance Review of ATXI
On Monday, Avenue Therapeutics Inc [NASDAQ:ATXI] saw its stock fall -5.21% to $2.00. Over the last five days, the stock has lost -1.23%. Avenue Therapeutics Inc shares have fallen nearly -83.44% since the year began. Nevertheless, the stocks have fallen -95.48% over the past one year. While a 52-week high of $44.99 was reached on 01/04/24, a 52-week low of $1.70 was recorded on 10/17/24. SMA at 50 days reached $2.49, while 200 days put it at $6.26.
Levels Of Support And Resistance For ATXI Stock
The 24-hour chart illustrates a support level at 1.73, which if violated will result in even more drops to 1.45. On the upside, there is a resistance level at 2.49. A further resistance level may holdings at 2.97. The Relative Strength Index (RSI) on the 14-day chart is 37.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been 70.00 at 70.00%. Stochastics %K at 38.02% indicates the stock is a holding.
How much short interest is there in Avenue Therapeutics Inc?
A steep rise in short interest was recorded in Avenue Therapeutics Inc stocks on 2024-09-30, dropping by 5111.0 shares to a total of 31536.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 36647.0 shares. There was a decline of -16.21%, which implies that there is a negative sentiment for the stock.
